MX9100647A - Nuevos 19-nor-esteroides que tienen en posicion ii beta una cadena carbonada que contiene una funcion amida,su preparacion,su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen - Google Patents

Nuevos 19-nor-esteroides que tienen en posicion ii beta una cadena carbonada que contiene una funcion amida,su preparacion,su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen

Info

Publication number
MX9100647A
MX9100647A MX9100647A MX9100647A MX9100647A MX 9100647 A MX9100647 A MX 9100647A MX 9100647 A MX9100647 A MX 9100647A MX 9100647 A MX9100647 A MX 9100647A MX 9100647 A MX9100647 A MX 9100647A
Authority
MX
Mexico
Prior art keywords
hydrogen
preparation
pharmaceutical compositions
application
amida
Prior art date
Application number
MX9100647A
Other languages
English (en)
Inventor
Andre Claussner
Francois Nique
Jean Georges Teutsch
Patrick Van De Velde
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9010323A external-priority patent/FR2665901B2/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MX9100647A publication Critical patent/MX9100647A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9100647A 1990-08-14 1991-08-13 Nuevos 19-nor-esteroides que tienen en posicion ii beta una cadena carbonada que contiene una funcion amida,su preparacion,su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen MX9100647A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9010323A FR2665901B2 (fr) 1989-02-24 1990-08-14 Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.

Publications (1)

Publication Number Publication Date
MX9100647A true MX9100647A (es) 1992-04-01

Family

ID=9399655

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100647A MX9100647A (es) 1990-08-14 1991-08-13 Nuevos 19-nor-esteroides que tienen en posicion ii beta una cadena carbonada que contiene una funcion amida,su preparacion,su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen

Country Status (15)

Country Link
EP (1) EP0471612B1 (es)
JP (1) JP3073803B2 (es)
KR (1) KR920004408A (es)
AT (1) ATE162797T1 (es)
AU (1) AU644671B2 (es)
CA (1) CA2049102A1 (es)
DE (1) DE69128820T2 (es)
DK (1) DK0471612T3 (es)
ES (1) ES2112268T3 (es)
GR (1) GR3026315T3 (es)
HU (1) HUT59416A (es)
IE (1) IE912863A1 (es)
MX (1) MX9100647A (es)
PT (1) PT98681B (es)
ZA (1) ZA916420B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
ES2102830T3 (es) * 1993-01-21 1997-08-01 Merrell Pharma Inc Diarilalquil piperidinas utiles como agentes para tumores con resistencia multifarmaco.
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.
US5670521A (en) * 1994-08-05 1997-09-23 Merrell Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
DE19724187A1 (de) * 1997-06-02 1998-12-03 Schering Ag 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
AU6228299A (en) * 1998-10-29 2000-05-22 Teikoku Hormone Mfg. Co., Ltd. 2-substituted-d-homooxasteroid derivatives
DE19929715A1 (de) * 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
BR112013011188B1 (pt) 2010-11-05 2022-01-04 Senomyx, Inc Método não-médico para modular canal potencial de receptor transiente de melastina 8 (trpm8), método não-médico para modular a sensação de resfriamento de uma composição, método não-médico para induzir uma sensação de resfriamento em um humano ou animal e composto
EP3356356B1 (en) 2015-10-01 2021-05-26 Firmenich Incorporated Compounds useful as modulators of trpm8

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235949B1 (es) * 1973-06-18 1978-03-17 Roussel Uclaf
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions
DE3621024C2 (de) * 1986-06-20 1999-10-28 Schering Ag 11beta-Phenylestradiene, deren Herstellung und diese enthaltende pharmazeutische Präparate
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
DE69128820D1 (de) 1998-03-05
PT98681B (pt) 1999-01-29
HU912690D0 (en) 1992-01-28
DK0471612T3 (da) 1999-02-22
CA2049102A1 (fr) 1992-02-15
ZA916420B (en) 1992-10-28
IE912863A1 (en) 1992-02-26
AU644671B2 (en) 1993-12-16
AU8242291A (en) 1992-02-20
EP0471612B1 (fr) 1998-01-28
HUT59416A (en) 1992-05-28
JP3073803B2 (ja) 2000-08-07
DE69128820T2 (de) 1998-06-10
EP0471612A3 (en) 1992-05-13
ATE162797T1 (de) 1998-02-15
ES2112268T3 (es) 1998-04-01
JPH06340688A (ja) 1994-12-13
KR920004408A (ko) 1992-03-27
EP0471612A2 (fr) 1992-02-19
GR3026315T3 (en) 1998-06-30
PT98681A (pt) 1992-07-31

Similar Documents

Publication Publication Date Title
MX9100647A (es) Nuevos 19-nor-esteroides que tienen en posicion ii beta una cadena carbonada que contiene una funcion amida,su preparacion,su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen
DE69214755D1 (de) Thiazolidin-2,4-Dionderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69627042T2 (de) Isocumarinderivate und deren verwendung in medikamenten
ATE162709T1 (de) Oberflächenaktivmittelfreie aerosolformulierungen enthaltend beclomethason dipropionat
ES2062431T3 (es) Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena carbonada que comprende una funcion amida o carbamato, su procedimiento de preparacion y los productos intermedios de este procedimiento, su aplicacion como medicamentos, y composiciones farmaceuticas que los conti
FI935728A (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES2099551T3 (es) Nuevos 19-nor-esteroides que tienen en posicion 11 beta una cadena de fenoxialquilsulfonamida o fenoxialquilsulfonilurea, procedimiento y productos intermedios de preparacion, aplicacion como medicamentos y composicion farmaceutica que los contiene.
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
ATE110269T1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
ATE131049T1 (de) Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen.
MX9207395A (es) Tiazoles novedosos.
DE69902925T2 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
DE69008282T2 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
IT8125895A0 (it) Tetraidro-1,2,4-ossadiazin-5-one derivati sostituiti aventi attivita' anti convulsiva, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
ATE2003T1 (de) 1-(heterocyclylalkyl)-1,3-dihydro-2h-benzimidaz l-2-one, verfahren zu deren herstellung, ihre pharmazeutischen zusammensetzungen und ihre verwendung als beta-adrenolytika.
ATE18994T1 (de) Neue pharmazeutische zusammensetzung.
FR2363567A1 (fr) Nouveaux derives de la u-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone, leur preparation et leur application en tant que medicaments
ATE4713T1 (de) 2-oxo-benzothiazolin-, benzoxazolin- oder indolin-derivate, deren herstellung und derartige verbindungen enthaltende pharmazeutische zusammensetzungen.
FI824526A0 (fi) Anvaendning som aktiv bestaondsdel foer framstaellning av en farmaceutisk komposition av ett strukturelement, foeretraedesvis i terminalstaellning
IT8025473A0 (it) Derivati piridossinici ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
SE8503037D0 (sv) Extendable platform scale, f i for weighing of patients in hospitals
ATE4666T1 (de) Eburnan-derivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.